BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34246382)

  • 1. Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease.
    Rendo M; Franks TJ; Galvin JR; Berglund A; Volk C; Peterson M
    Chest; 2021 Jul; 160(1):e13-e17. PubMed ID: 34246382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kappa light chain deposition disease, presenting as Sjögren's syndrome, successfully treated by high-dose melphalan and autologous blood stem transplantation].
    Foguem C; Kantelip B; Deconinck E; Hafsaoui C; Méaux-Ruault N; Gil H; Magy-Bertrand N; Dupond JL
    Rev Med Interne; 2009 Jan; 30(1):49-52. PubMed ID: 18801600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary manifestations of light chain deposition disease.
    Rho L; Qiu L; Strauchen JA; Gordon RE; Teirstein AS
    Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An unusual cause of cystic lung disease: light chain deposition disease].
    Luraine R; Sohier L; Kerjouan M; Desrues B; Delaval P; Jouneau S
    Rev Mal Respir; 2013 Sep; 30(7):567-71. PubMed ID: 24034462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease.
    Matsuzaki K; Ohsawa I; Nishitani T; Takeda Y; Inoshita H; Ishii M; Takagi M; Horikoshi S; Tomino Y
    J Nephrol; 2011; 24(2):246-9. PubMed ID: 21240874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood stem cell transplantation to treat cystic lung light chain deposition disease.
    Borgne AL; Prévot G; Rouquette I; Huynh A; Têtu L; Projetti F; Carreiro M; Borie R; Jaccard A; Recher C; Didier A
    Eur Respir J; 2015 Oct; 46(4):1199-202. PubMed ID: 26160867
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
    Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
    Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of paraproteinemic renal disease.
    Sanders PW
    Curr Opin Nephrol Hypertens; 2005 Mar; 14(2):97-103. PubMed ID: 15687834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light- and heavy-chain deposition disease (LHCDD): difficulty in diagnosis and treatment.
    Suzuki K
    Intern Med; 2005 Sep; 44(9):915-6. PubMed ID: 16258202
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous stem cell transplant for light chain deposition disease: incorporating bortezomib to the induction therapy.
    Jimenez-Zepeda VH; Trudel S; Winter A; Reece DE; Chen C; Kukreti V
    Am J Hematol; 2012 Aug; 87(8):822-3. PubMed ID: 22641434
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary diseases and non-amyloid light chain deposition].
    Colombat M; Stern M
    Rev Mal Respir; 2013 Sep; 30(7):524-6. PubMed ID: 24034455
    [No Abstract]   [Full Text] [Related]  

  • 14. [Light chain deposition disease].
    Sčudla V; Minařík J; Pika T
    Vnitr Lek; 2012 Jan; 58(1):38-43. PubMed ID: 22448699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation.
    Sánchez Quintana A; Rull PR; Atienza JB; McDonnell CN
    Nephrology (Carlton); 2013 Sep; 18(9):641-3. PubMed ID: 23980813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation.
    Firkin F; Hill PA; Dwyer K; Gock H
    Am J Kidney Dis; 2004 Sep; 44(3):551-5. PubMed ID: 15332228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
    Sivaraj D; Green MM; Ciftci AM; Zahid MF; Johns AA; Ross M; Gasparetto C
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e95-e100. PubMed ID: 27101986
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paraproteinemia and renal diseases].
    Grandjean AP; Dettwiler S; Saudan P
    Rev Med Suisse; 2010 Mar; 6(238):460-6. PubMed ID: 20344997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose melphalan followed by auto-SCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease.
    Telio D; Shepherd J; Forrest D; Zypchen L; Barnett M; Nevill T; Song KW
    Bone Marrow Transplant; 2012 Mar; 47(3):453-5. PubMed ID: 21499318
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pulmonary light chain deposition disease from a respiratory physician's perspective].
    Shi JH
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):501-503. PubMed ID: 38858199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.